Lunit SCOPE GP
Al-Powered Genotype Predictor from H&E
Research Use Only, Not for use in diaanostic procedures
Rapid AI-powered prediction of tumor genotype from H&E
Benefits
Clinical Trials
Quickly pre-screen patients
for clinical trial enrollment
Drug Development
Develop novel AI signatures from H&E to
predict therapy response and resistance
Lunit Announces Collaboration with AstraZeneca to Develop
AI-Powered Digital Pathology Risk Assessment Tools for NSCLC
Based on H&E slide analysis,
Lunit SCOPE GP offers insights into tumor
genomics and molecular characteristics
Key Features
Lunit SCOPE GP is developed with multiple methods in a novel way to improve performance
Combining Unsupervised + Supervised Learning to improve predictive power
We can build and fine-tune models according to your needs
Quick Development
Performance tests within weeks,
based on the core model
Flexible Data Sourcing
Rapid sourcing of high quality
data from diverse geographies
非常抱歉,您只有购买软件后才能查看完整软件教程!